Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

No "Cert"-ainty On Reverse Settlements: Supreme Court Declines To Take Up Case

This article was originally published in The Pink Sheet Daily

Executive Summary

Lower courts had found Bayer’s agreement with Barr and Hoechst to delay generic Cipro to be lawful; Second Circuit is to rule on the deal.

You may also be interested in...



Reverse Settlements Are Acceptable Under Certain Conditions, DoJ Says

Brand company payments to generic firms to settle infringement suits may not violate antitrust laws if they permit some competition, Department of Justice concludes.

Reverse Settlements Are Acceptable Under Certain Conditions, DoJ Says

Brand company payments to generic firms to settle infringement suits may not violate antitrust laws if they permit some competition, Department of Justice concludes.

FTC's Health Care Reform Plan: Save $12 Billion With Reverse Settlement Ban

The Federal Trade Commission has drawn another arrow in its attempt to shoot down reverse settlements between brand and generic drug companies - offering an estimate of $12 billion in government savings over the next 10 years from ending the practice

Related Content

Topics

UsernamePublicRestriction

Register

LL1126093

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel